Center Offers Innovative New Technology
for Diagnosing and Staging Lung Cancer
The Center for Lung & Chest Surgery has added new technology for diagnosing and staging lung cancer the endobronchial ultrasound (EBUS) transbronchial needle aspiration (TBNA) system from Olympus.
"In our effort to increase the quality of patient care, we have acquired this innovative technology," says Louis DeCunzo, Jr., MD, Medical Director of the Center. "As the leading cause of cancer-related deaths among both men and women in the U.S., earlier detection of lung cancer along with accurate diagnosis and staging are critical to patient outcomes."
Evaluating lymph glands within the chest is often a critical part of the diagnosis and staging of patients diagnosed with or suspected of having a lung cancer. According to Dr. DeCunzo, the EBUS system's design enables physicians to visualize lymph nodes and surrounding blood vessels in the chest in real-time, via ultrasound, while simultaneously viewing the endoscopic image.
Done as an outpatient procedure, the EBUS system is designed for safer and more accurate diagnostic biopsies and offers a less-invasive alternative to conventional surgical biopsies. In addition, while the main indication for EBUS-TBNA system is the diagnosis and staging of lung cancer, certain non-cancerous conditions which may cause lymph gland enlargement can also be diagnosed with EBUS-TBNA.
For more information on this new technology, please contact the Center for Lung & Chest Surgery at (518) 926-5864.